Skip to main content

Piperacillin and Tazobactam for Injection

Type of Posting: Revision Bulletin

Posting Date: 24–Dec–2009; updated 18–Mar–2010

Official Date: 01–Feb–2010

Expert Committee: Monograph Development—Antibiotics

In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Monograph Development—Antibiotics Expert Committee has revised the Piperacillin and Tazobactam for Injection Monograph. The purpose for the change is that the monograph revision sponsor received FDA approval for less stringent limits for pH and Particulate Matter.

The Piperacillin and Tazobactam for Injection Revision Bulletin supersedes the currently official monograph and will be incorporated in the Second Supplement to the USP 33–NF 28 Reissue and the monograph will be in the redesigned format at that time. USP also will retain the original, non-redesigned version with this Revision Bulletin.

Should you have any questions, please contact Ahalya Wise (301-816-8161 or aww@usp.org).